Seeking Alpha

herbert hoover » Comments » ARQL

  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up  [View article]
    There seem to be a few biotechs that generate tons of shorting by a certain Big Player - look what was done to DNDN. Unfortunately there seems to be a concerted effort to actively short SPPI in the same manner. Basically the same players, using the same methods, in a very methodical manner.

    I dumped my shares because of this.
    Sep 12 16:56 pm |Rating: 0 0 |Link to Comment
More on ARQL by herbert hoover
Comments by Ticker
AA, AAPL, AAUKY.PK, ABK, ACE, ACI, ADBE, ADM, ADY, AEG, AET, AFG, AFL, AGU, AHBIF.PK, AIG, AIN, AKS, ALL, ALTH, ALV, AMAT, AMD, AMED, AMSC, AMSF, AMX, AMZN, ANR, APA, APC, APWR, ARIA, ARQL, ASML, ATVI, AVAV, AXP, AYI, AZN, BA, BAC, BAYRY.PK, BBT, BBY, BCRX, BCS.PD, BDSI, BEXP, BEZ,
herbert hoover is a
Top 100 Commentor
1400 comments
Rating: 1272 (2401 - 1129 )